Literature DB >> 28466401

Is levothyroxine requirement the same for tablet and soft gel formulations?

Vincenzo Di Donna1, Rosa Maria Paragliola1, Chiara de Waure2, Giampaolo Papi1, Alfredo Pontecorvi1, Salvatore Maria Corsello3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28466401     DOI： 10.1007/s12020-017-1311-8

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  17 in total

1.  Comparative study between the effects of replacement therapy with liquid and tablet formulations of levothyroxine on mood states, self-perceived psychological well-being and thyroid hormone profile in recently thyroidectomized patients.

Authors:  Celestino Pio Lombardi; Raffaella Bocale; Angelina Barini; Antonella Barini; Annamaria D'Amore; Mauro Boscherini; Rocco Bellantone
Journal:  Endocrine       Date:  2016-07-07       Impact factor: 3.633

2.  Treatment of hypothyroidism: all that glitters is gold?

Authors:  Anna Maria Formenti; Gherardo Mazziotti; Raffaele Giubbini; Andrea Giustina
Journal:  Endocrine       Date:  2016-02-29       Impact factor: 3.633

3.  Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism.

Authors:  Davide Brancato; Alessandro Scorsone; Gabriella Saura; Lidia Ferrara; Anna Di Noto; Vito Aiello; Mattia Fleres; Vincenzo Provenzano
Journal:  Endocr Pract       Date:  2014-07       Impact factor: 3.443

4.  Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Alessandro Antonelli
Journal:  Endocrine       Date:  2015-12-31       Impact factor: 3.633

5.  A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.

Authors:  Roberto Vita; Giovanna Saraceno; Francesco Trimarchi; Salvatore Benvenga
Journal:  Endocrine       Date:  2012-08-30       Impact factor: 3.633

6.  Predicting thyroxine requirements following total thyroidectomy.

Authors:  Dipan Mistry; Stephen Atkin; Helen Atkinson; Sinnappa Gunasekaran; Deborah Sylvester; Alan S Rigby; R James England
Journal:  Clin Endocrinol (Oxf)       Date:  2011-03       Impact factor: 3.478

7.  Levothyroxine liquid solution versus tablet for replacement treatment in hypothyroid patients.

Authors:  Roberto Negro; Roberto Valcavi; Daniela Agrimi; Konstantinos A Toulis
Journal:  Endocr Pract       Date:  2014-09       Impact factor: 3.443

8.  Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism.

Authors:  Alessandra Cassio; Sara Monti; Angela Rizzello; Ilaria Bettocchi; Federico Baronio; Graziana D'Addabbo; Milva Orquidea Bal; Antonio Balsamo
Journal:  J Pediatr       Date:  2013-01-11       Impact factor: 4.406

Review 9.  The administration of L-thyroxine as soft gel capsule or liquid solution.

Authors:  Roberto Vita; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga
Journal:  Expert Opin Drug Deliv       Date:  2014-06-04       Impact factor: 6.648

10.  Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine.

Authors:  Elena Peroni; Maria Cristina Vigone; Stefano Mora; Lorenzo Andrea Bassi; Clara Pozzi; Arianna Passoni; Giovanna Weber
Journal:  Horm Res Paediatr       Date:  2013-11-12       Impact factor: 2.852
View more
  8 in total

Review 1.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

Review 2.  Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism.

Authors:  Pierpaolo Trimboli; Stéphane Mouly
Journal:  J Clin Med       Date:  2022-06-16       Impact factor: 4.964

Review 3.  Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.

Authors:  Salvatore Benvenga; Allan Carlé
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845

Review 4.  Levothyroxine Therapy in Thyrodectomized Patients.

Authors:  Paolo Miccoli; Gabriele Materazzi; Leonardo Rossi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-29       Impact factor: 5.555

Review 5.  L-T4 Therapy in Enteric Malabsorptive Disorders.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Alessandro Antonelli
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-23       Impact factor: 5.555

6.  Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption.

Authors:  Pierpaolo Trimboli; Camilla Virili; Marco Centanni; Luca Giovanella
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-21       Impact factor: 5.555

7.  Different Formulations of Levothyroxine for Treating Hypothyroidism: A Real-Life Study.

Authors:  Pierpaolo Trimboli; Lorenzo Scappaticcio; Annamaria De Bellis; Maria Ida Maiorino; Luisa Knappe; Katherine Esposito; Giuseppe Bellastella; Luca Giovanella
Journal:  Int J Endocrinol       Date:  2020-01-20       Impact factor: 3.257

Review 8.  The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.

Authors:  Alessandro Antonelli; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Gabriella Cavallini; Salvatore Benvenga; Silvia Martina Ferrari; Poupak Fallahi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-10       Impact factor: 5.555
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.